Key facts
- It has raised $157.6M; the latest was Later Stage VC ($131.0M) in Mar 2026.
- Notable investors include General Atlantic, Square Peg Capital, Cerca Partners, J.P. Morgan (New York), J.P. Morgan — 15 tracked in total.
- Status: Privately Held (backing).
Leadership
- Jake LeverVice President
- Omri YoffeChief Executive Officer & Founder
- Spencer HoneymanExecutive Officer
- Vixx NishikawaExecutive
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Vi Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Vi Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vi Labs
Developer of an enterprise AI platform designed for health to drive results at scale. The company's technology stack and extensive household-level data leverage predictive and personalized engagement frameworks, reducing cost per acquisition, maximizing member lifetime value, and ultimately improving member health outcomes, enabling organizations to maximize member health outcomes and financial returns.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Employees
- 175
- Website
- vi.co/
- Ownership
- Privately Held (backing)
Vi Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vi Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vi Labs in its N-PORT filings yet. We sweep new filings monthly.